Yarrow Bioscience (YARW) Operating Leases (2019 - 2024)

Yarrow Bioscience (YARW) has reported Operating Leases for 5 consecutive years, with $99000.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Operating Leases fell 53.74% year-over-year to $99000.0; the trailing twelve-month figure through Dec 2024 stood at $99000.0 (down 53.74% YoY), and the FY2024 full-year result was $99000.0, down 53.74% from the prior year.
• Operating Leases rose to $99000.0 in Q4 2024 per YARW's latest filing, from $25000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $2.6 million in Q2 2020 and bottomed at $25000.0 in Q2 2024.
• Historically, Operating Leases has averaged $963250.0 across 4 years, with a median of $889500.0 in 2020.
• The sharpest annual moves came in 2020 and 2021: Operating Leases soared 257.06% in 2020, then tumbled 78.32% in 2021.
• Over 4 years, Operating Leases stood at $1.6 million in 2020, then sank by 78.32% to $349000.0 in 2021, then plunged by 38.68% to $214000.0 in 2023, then slumped by 53.74% to $99000.0 in 2024.
• According to Business Quant data, Operating Leases over the past three periods registered $99000.0, $25000.0, and $63000.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.